LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.0056667
 27.49 27.76 46 1723 0.0267 0.0885
MN20160318_Q01
N13
MCF 10A-H2B-mCherry Trametinib
0.0056667
 27.49 27.76 1442 1723 0.8368 0.9411
MN20160318_Q01
N13
MCF 10A-H2B-mCherry Trametinib
0.0056667
 29.19 27.76 1433 1863 0.7691 0.9153
MN20160318_Q01
I11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 29.19 27.76 1505 1863 0.8078 0.9309
MN20160318_Q01
I11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 29.19 27.76 67 1863 0.0360 0.1563
MN20160318_Q01
N13
MCF 10A-H2B-mCherry Trametinib
0.0056667
 29.19 27.76 1466 1863 0.7868 0.9225
MN20160318_Q01
N13
MCF 10A-H2B-mCherry Trametinib
0.0056667
 30.90 27.76 1420 2032 0.6987 0.8875
MN20160318_Q01
I11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 30.90 27.76 1479 2032 0.7277 0.9000
MN20160318_Q01
I11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 30.90 27.76 75 2032 0.0369 0.1741
MN20160318_Q01
N13
MCF 10A-H2B-mCherry Trametinib
0.0056667
 30.90 27.76 1555 2032 0.7651 0.9154
MN20160318_Q01
N13
MCF 10A-H2B-mCherry Trametinib
0.0056667
 32.60 27.76 1521 2235 0.6803 0.8819
MN20160318_Q01
I11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 32.60 27.76 1582 2235 0.7076 0.8937
MN20160318_Q01
I11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 32.60 27.76 103 2235 0.0461 0.2301
MN20160318_Q01
N13
MCF 10A-H2B-mCherry Trametinib
0.0056667
 32.60 27.76 1567 2235 0.7009 0.8908
MN20160318_Q01
N13
MCF 10A-H2B-mCherry Trametinib
0.0056667
 34.30 27.76 1509 2449 0.6160 0.8556
MN20160318_Q01
I11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 34.30 27.76 1554 2449 0.6343 0.8640
MN20160318_Q01
I11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 34.30 27.76 91 2449 0.0371 0.2017
MN20160318_Q01
N13
MCF 10A-H2B-mCherry Trametinib
0.0056667
 34.30 27.76 1460 2449 0.5960 0.8461
MN20160318_Q01
N13
MCF 10A-H2B-mCherry Trametinib
0.0056667
 36.01 27.76 1626 2662 0.6106 0.8556
MN20160318_Q01
I11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 36.01 27.76 1670 2662 0.6271 0.8632
MN20160318_Q01
I11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 36.01 27.76 122 2662 0.0458 0.2522
MN20160318_Q01
N13
MCF 10A-H2B-mCherry Trametinib
0.0056667
 36.01 27.76 1623 2662 0.6095 0.8551
MN20160318_Q01
N13
MCF 10A-H2B-mCherry Trametinib
0.0056667
 37.71 27.76 1642 2877 0.5706 0.8392
MN20160318_Q01
I11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 37.71 27.76 1694 2877 0.5887 0.8478
MN20160318_Q01
I11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 37.71 27.76 140 2877 0.0487 0.2734
MN20160318_Q01
N13